We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$202M
AUM Growth
+$11.2M
Cap. Flow
+$176K
Cap. Flow %
0.09%
Top 10 Hldgs %
63.71%
Holding
385
New
9
Increased
31
Reduced
46
Closed
27

Sector Composition

Rank Sector Weight
1 Real Estate 1.83%
2 Healthcare 0.58%
3 Technology 0.54%
4 Financials 0.48%
5 Consumer Staples 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
276
LKQ Corp
LKQ
$5.91B
$4K ﹤0.01%
133
MPWR icon
277
Monolithic Power Systems
MPWR
$66B
$4K ﹤0.01%
43
NSC icon
278
Norfolk Southern
NSC
$75.6B
$4K ﹤0.01%
40
PSA icon
279
Public Storage
PSA
$60.9B
$4K ﹤0.01%
20
TSCO icon
280
Tractor Supply
TSCO
$16.8B
$4K ﹤0.01%
315
TSLA icon
281
Tesla
TSLA
$1.27T
$4K ﹤0.01%
195
WP
282
DELISTED
Worldpay, Inc.
WP
$4K ﹤0.01%
69
POT
283
DELISTED
Potash Corp Of Saskatchewan
POT
$4K ﹤0.01%
212
WNR
284
DELISTED
Western Refining Inc
WNR
$4K ﹤0.01%
100
BMRN icon
285
BioMarin Pharmaceuticals
BMRN
$11.6B
$3K ﹤0.01%
39
COST icon
286
Costco
COST
$423B
$3K ﹤0.01%
20
EEFT icon
287
Euronet Worldwide
EEFT
$2.8B
$3K ﹤0.01%
39
FTNT icon
288
Fortinet
FTNT
$120B
$3K ﹤0.01%
415
-1,500
-78% -$10.6K
INCY icon
289
Incyte
INCY
$24B
$3K ﹤0.01%
24
OKE icon
290
Oneok
OKE
$55.6B
$3K ﹤0.01%
53
PCTY icon
291
Paylocity
PCTY
$7.48B
$3K ﹤0.01%
89
RARE icon
292
Ultragenyx Pharmaceutical
RARE
$2.46B
$3K ﹤0.01%
44
REGN icon
293
Regeneron Pharmaceuticals
REGN
$78.2B
$3K ﹤0.01%
9
RLY icon
294
State Street Multi-Asset Real Return ETF
RLY
$1.26B
$3K ﹤0.01%
+121
New +$2.98K
STZ icon
295
Constellation Brands
STZ
$22.4B
$3K ﹤0.01%
21
VRTX icon
296
Vertex Pharmaceuticals
VRTX
$119B
$3K ﹤0.01%
23
CRZO
297
DELISTED
Carrizo Oil & Gas Inc
CRZO
$3K ﹤0.01%
100
ESRX
298
DELISTED
Express Scripts Holding Company
ESRX
$3K ﹤0.01%
49
ADBE icon
299
Adobe
ADBE
$99.9B
$2K ﹤0.01%
18
AVGO icon
300
Broadcom
AVGO
$1.87T
$2K ﹤0.01%
110

Similar funds

Roble Belko & Company's Q1 2017 Portfolio in Review

As of Q1 2017, Roble Belko & Company held 385 positions worth $202M, up 5.9% from $191M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Roble Belko & Company's Q1 2017 filing shows 9 new, 31 increased, 46 reduced and 27 closed positions. Its largest new stake was iShares iBonds Dec 2020 Term Corporate ETF: 9,884 shares worth $251K. The largest sale was Vanguard Real Estate ETF, an estimated $1.97M.

By sector, the portfolio is most concentrated in Real Estate at 1.8% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Technology.

  • Roble Belko & Company's largest Q1 2017 buy was iShares iBonds Dec 2020 Term Corporate ETF: 9,884 shares worth $251K.
  • Roble Belko & Company added most to Vanguard Total International Stock ETF in Q1 2017, an estimated $2.09M increase.
  • Roble Belko & Company's biggest Q1 2017 reduction was Vanguard Real Estate ETF, cutting an estimated $1.97M.
  • Roble Belko & Company fully exited Apollo Commercial Real Estate in Q1 2017, selling an estimated $1.93M.
  • Roble Belko & Company's ten largest holdings make up 64% of its $202M portfolio in Q1 2017.
  • Roble Belko & Company opened 9 new positions and closed 27 in Q1 2017.
  • Roble Belko & Company's portfolio value rose 5.9% quarter-over-quarter to $202M.

Based on Roble Belko & Company's 13F filing for Q1 2017, filed 12 May 2017.